OK Biotech Co (TPE:4155) Beginning Cash Position: NT$314 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4155 OK Biotech Co Ltd TPE:4155
68 GF Score
Price NT$14.40
GF Value NT$23.94
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is OK Biotech Co Beginning Cash Position?

OK Biotech Co TPE:4155 68 Beginning Cash Position is NT$314 Mil as of Mar. 2026. GuruFocus rates TPE:4155 with a GF Score™ of 68/100 and a GF Value™ of NT$23.94 (Possible Value Trap). The stock has 6 warning signs investors should review.

OK Biotech Co's Beginning Cash Position for the quarter that ended in Mar. 2026 was NT$314 Mil.

OK Biotech Co's quarterly Beginning Cash Position increased from Sep. 2025 (NT$166 Mil) to Dec. 2025 (NT$303 Mil) and increased from Dec. 2025 (NT$303 Mil) to Mar. 2026 (NT$314 Mil).

OK Biotech Co's annual Beginning Cash Position declined from Dec. 2023 (NT$596 Mil) to Dec. 2024 (NT$323 Mil) and declined from Dec. 2024 (NT$323 Mil) to Dec. 2025 (NT$277 Mil).

OK Biotech Co Beginning Cash Position Related Terms

OK Biotech Co Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for OK Biotech Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OK Biotech Co Beginning Cash Position Chart

OK Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 566.72 599.85 596.42 323.03 277.46

OK Biotech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 277.46 301.79 166.19 303.48 314.47
TPE:4155
68GF Score
OK Biotech Co Ltd TPE:4155
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OK Biotech Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of NT$314 Mil mean?
OK Biotech Co (TPE:4155) has a Beginning Cash Position of NT$314 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on OK Biotech Co and its competitors.
Is OK Biotech Co's Beginning Cash Position too high?
OK Biotech Co's current Beginning Cash Position is NT$314 Mil. Overall, OK Biotech Co has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does OK Biotech Co's Beginning Cash Position compare to ABT and SYK?
OK Biotech Co's Beginning Cash Position of NT$314 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on OK Biotech Co and its competitors. OK Biotech Co's current Beginning Cash Position is NT$314 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OK Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, OK Biotech Co (TPE:4155) is currently considered Possible Value Trap. The stock's GF Value™ is NT$23.94, compared to a current price of NT$14.40 — trading 39.8% below its estimated fair value. The current Beginning Cash Position is NT$314 Mil. OK Biotech Co's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For OK Biotech Co (TPE:4155), the current Beginning Cash Position is NT$314 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OK Biotech Co (TPE:4155) Overvalued in 2026?

Based on GuruFocus' analysis, OK Biotech Co stock appears to be undervalued. The current stock price of NT$14.40 is trading 39.8% below its estimated GF Value™ of NT$23.94. GuruFocus considers OK Biotech Co to be Possible Value Trap.

Key valuation signals for TPE:4155:

  • Beginning Cash Position: NT$314 Mil
  • GF Value™: NT$23.94 vs. price of NT$14.40 (39.8% below fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the TPE:4155 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OK Biotech Co Business Description

Address Gongdao 5th Road, Section 2, No. 91, Hsinchu, TWN, 30070
OK Biotech Co Ltd is mainly engaged in the manufacturing, wholesale, and retail of electronic materials and medical equipment. Its product portfolio comprises blood glucose monitoring systems, OTC hearing aids, multi-frequency therapy devices, and others. Geographically, the company generates the majority of its revenue from America, and the rest from Asia (excluding Taiwan), Africa, Europe, and Taiwan.
68GF Score

Get the complete analysis for TPE:4155

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$14.40
Price
NT$23.94
GF Value